Literature DB >> 14616682

An outbreak of carbapenem-resistant Pseudomonas aeruginosa in a urology ward.

C Peña1, M A Dominguez, M Pujol, R Verdaguer, F Gudiol, J Ariza.   

Abstract

OBJECTIVE: To investigate an outbreak of carbapenem-resistant Pseudomonas aeruginosa (CRPA) in a urology ward.
METHODS: Patients infected or colonized with CRPA were prospectively identified by daily laboratory surveillance. Routine infection-control measures were reinforced, disinfection protocols were revised, and a surveillance program was set up, analyzing cross-transmission in the nursing ward and environment cultures from urology wards and the operating theater. CRPA isolates from clinical and environment samples were studied by pulsed-field gel electrophoresis (PFGE), following XbaI and SpeI restriction.
RESULTS: From February 1998 to September 2000, 59 adult urology patients were colonized or infected by CRPA. All patients had been operated on prior to identification of the CRPA isolate and 79% of these procedures were performed in the same cystoscopy room. No patients had received prior carbapenem therapy. No cross-transmission was detected, and environment cultures from the urology ward and theater were negative except for five samples collected in the cystoscopy room. PFGE identified a single clone in the isolates from different patients and the environment samples.
CONCLUSIONS: The PFGE analysis indicated that the CRPA outbreak resulted from the contamination of the cystoscopy room via an unsealed drain. The outbreak ended when the drain was sealed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14616682     DOI: 10.1046/j.1469-0691.2003.00686.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

1.  Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals.

Authors:  María García-Castillo; Rosa Del Campo; María Isabel Morosini; Elena Riera; Gabriel Cabot; Rob Willems; Rosa van Mansfeld; Antonio Oliver; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

Review 2.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

3.  Contaminated mouth swabs caused a multi-hospital outbreak of Pseudomonas aeruginosa infection.

Authors:  Bjørn G Iversen
Journal:  J Oral Microbiol       Date:  2010-04-20       Impact factor: 5.474

4.  A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition.

Authors:  Cristina Suarez; Carmen Peña; Olga Arch; M Angeles Dominguez; Fe Tubau; Carlos Juan; Laura Gavaldá; Mercedes Sora; Antonio Oliver; Miquel Pujol; Javier Ariza
Journal:  BMC Infect Dis       Date:  2011-10-13       Impact factor: 3.090

5.  Pseudomonas aeruginosa contamination of mouth swabs during production causing a major outbreak.

Authors:  Bjørn G Iversen; Hanne-Merete Eriksen; Gjermund Bø; Kristian Hagestad; Trond Jacobsen; Eva Engeset; Jørgen Lassen; Preben Aavitsland
Journal:  Ann Clin Microbiol Antimicrob       Date:  2007-03-13       Impact factor: 3.944

6.  Drainage systems, an occluded source of sanitation related outbreaks.

Authors:  Kristina Blom
Journal:  Arch Public Health       Date:  2015-02-26

7.  Contamination of microbial pathogens and their antimicrobial pattern in operating theatres of peri-urban eastern Uganda: a cross-sectional study.

Authors:  Sandra Matinyi; Muwanguzi Enoch; Deborah Akia; Valentine Byaruhanga; Edson Masereka; Isaac Ekeu; Collins Atuheire
Journal:  BMC Infect Dis       Date:  2018-09-10       Impact factor: 3.090

8.  A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections.

Authors:  Qingyi Shi; Chen Huang; Tingting Xiao; Zhenzhu Wu; Yonghong Xiao
Journal:  Antimicrob Resist Infect Control       Date:  2019-04-25       Impact factor: 4.887

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.